IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-04014514.html
   My bibliography  Save this paper

Cost Analysis of Aprotinin Reintroduction in French Cardiac Surgery Centres: A Real-World Data-Based Analysis

Author

Listed:
  • Pascal Colson

    (Hôpital Arnaud de Villeneuve [CHRU Montpellier] - CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])

  • Jean-Luc Fellahi

    (Hôpital Louis Pradel [CHU - HCL] - HCL - Hospices Civils de Lyon, CarMeN - Cardiovasculaire, métabolisme, diabétologie et nutrition - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon - HCL - Hospices Civils de Lyon - INSERM - Institut National de la Santé et de la Recherche Médicale - INRAE - Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement)

  • Philippe Gaudard

    (PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique - UM - Université de Montpellier, Hôpital Arnaud de Villeneuve [CHRU Montpellier] - CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])

  • Sophie Provenchère

    (Service d'anesthésie - réanimation chirurgicale [CHU Bichat] - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) - AP-HP - Hôpital Bichat - Claude Bernard [Paris] - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) - UPCité - Université Paris Cité)

  • Bertrand Rozec

    (ITX-lab - ITX-lab unité de recherche de l'institut du thorax UMR1087 UMR6291 - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique - Nantes Univ - UFR MEDECINE - Nantes Université - UFR de Médecine et des Techniques Médicales - Nantes Université - pôle Santé - Nantes Univ - Nantes Université)

Abstract

Introduction: The European Medicines Agency restored aprotinin (APR) use for preventing blood loss in patients undergoing isolated coronary artery bypass graft (iCABG) in 2016 but requested the collection of patient and surgery data in a registry (NAPaR). The aim of this analysis was to evaluate the impact of APR reintroduction in France on the main hospital costs (operating room, transfusion and intensive unit stay) compared to the current use of tranexamic acid (TXA), which was the only antifibrinolytic available before APR reinstatement.Methods: A multicenter before-after post-hoc analysis to compare APR and TXA was carried out in four French university hospitals. APR use followed the ARCOTHOVA (French Association of Cardiothoracic and Vascular Anesthetists) protocol, which had framed three main indications in 2018. Data from 236 APR patients were retrieved from the NAPaR (N = 874); 223 TXA patients were retrospectively retrieved from each center database and matched to APR patients upon indication classes. Budget impact was evaluated using both direct costs associated with antifibrinolytics and transfusion products (within the first 48 h) and other costs such as surgery duration and ICU stay.Results: The 459 collected patients were distributed as: 17% on-label; 83% off-label. Mean cost per patient until ICU discharge tended to be lower in the APR group versus the TXA group, which resulted in an estimated gross saving of €3136 per patient. These savings concerned operating room and transfusion costs but were mainly driven by reduced ICU stays. When extrapolated to the whole French NAPaR population, the total savings of the therapeutic switch was estimated at around €3 million.Conclusion: The budget impact projected that using APR according to ARCOTHOVA protocol resulted in decreased requirement for transfusion and complications related to surgery. Both were associated with substantial cost savings from the hospital's perspective compared with exclusive use of TXA.

Suggested Citation

  • Pascal Colson & Jean-Luc Fellahi & Philippe Gaudard & Sophie Provenchère & Bertrand Rozec, 2023. "Cost Analysis of Aprotinin Reintroduction in French Cardiac Surgery Centres: A Real-World Data-Based Analysis," Post-Print hal-04014514, HAL.
    • Handle: RePEc:hal:journl:hal-04014514
    DOI: 10.1007/s12325-023-02464-7
    Note: View the original document on HAL open archive server: https://hal.science/hal-04014514
    as

    Download full text from publisher

    File URL: https://hal.science/hal-04014514/document
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s12325-023-02464-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-04014514. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.